Navigation Links
Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
Date:8/5/2008

going basis and

internally for operating, budgeting and financial planning purposes. Our

management excludes the effects of employee stock-based compensation

because of varying available valuation methodologies, subjective

assumptions and the variety of award types; such exclusion facilitates

comparisons of our operating results to our peer companies. Our

management believes the non-GAAP information is useful for investors by

offering them the ability to better identify trends in our business and

better understand how management evaluates our business.

These non-GAAP measures have limitations, however, because they do not

include all items of income and expense that affect Onyx. The non-GAAP

financial measures we use are not prepared in accordance with, and should

not be considered in isolation of, or as an alternative to, measurements

required by GAAP.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /P...daq: DCGN ) today announced that it has received n... the company,s common stock will be,suspended as o...d with the,Securities and Exchange Commission, whi...on Nasdaq, unless the company files an appeal to t...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstCal...aceutical company focused on developing and commer...ed today that Anthony DiTonno, President and Chief... 21st Annual Piper Jaffray Health Care Conference,...ace Hotel in New York, New York. ,, Mr. DiTonn...
(Date:11/24/2009)...TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNewswi... formerly Calotto Capital Inc., a leading provider... stem cell research and fertility clinic markets, ...or the third quarter ended September 30, 2009. , ... million compared with $1.43 million in Q3 2008, ...
(Date:11/24/2009)... Program Connects Customers with Partn...cted with DNA Genotek Products , ...NA Genotek , a leading provider of products for bi...aration, today announced its new global partner pr... for DNA Genotek,s partner community and is design...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...why Deb Rislow believes she has risen to her curre...ems for Gundersen Lutheran - at the perfect time...r been a hotter topic as the federal government tr...nd clinics apply it to reduce medical errors, cont... around long enough to have learned plenty of less...
... against potential infringers by licensing the pat...ing activity. Thanks to a recent Federal Circuit C...ce. , ,Typically, the patent owner would do this b...t a party agree to pay for a license and then nego...posals carried little risk of triggering unwanted ...
...h if the robotics engineering team from Benilde-St... had won a national championship against other hig...their competitors were seasoned college students. ...he Minneapolis-area school competed against gradua...boCup. Using robots to navigate a simulated disast...
Other Biology Technology:CIO Leadership Series: Deb Rislow, Gundersen Lutheran 2CIO Leadership Series: Deb Rislow, Gundersen Lutheran 3CIO Leadership Series: Deb Rislow, Gundersen Lutheran 4CIO Leadership Series: Deb Rislow, Gundersen Lutheran 5Patent licensing: For enforcing companies, the rules have changed 2Patent licensing: For enforcing companies, the rules have changed 3Silver linings in the cloud: America's dearth of STEM students 2Silver linings in the cloud: America's dearth of STEM students 3Silver linings in the cloud: America's dearth of STEM students 4
(Date:11/26/2009)...ts have at last worked out a way of using recordin...ird populations. This is the first time sound reco...d into accurate estimates of bird species, populat...ritish Ecological Society,s Journal of Applied Ec...ead to a major advance in our ability to monitor w...
(Date:11/26/2009)...elberg, 27 November 2009 What are the bare essent...ed to produce a cell that can survive on its own? ...nd understand how an entire organism functions as ...t scientists in a partnership between the European..., Germany, and the Centre de Regulacio Genmica (CR...
(Date:11/25/2009)... a hormone produced in the stomach, may be used to...Parkinson,s disease, Yale School of Medicine resea...ue of the Journal of Neuroscience . , Parkinson... neurons in an area of the midbrain known as the s... production. Reduced production of dopamine in la...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Sister to Sister to Host BIKE FOR THE HEART EVENT Sunday October 11th 58718 1Sister to Sister to Host BIKE FOR THE HEART EVENT Sunday October 11th 58718 2Oncolytics Biotech 28R 29 Inc Announces Phase 3 Update Conference Call 14322 1Oncolytics Biotech 28R 29 Inc Announces Phase 3 Update Conference Call 14322 2Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 1Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 2Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 3
...A investigators reviewed pharmaceutical ads in Ame...hird contained no references for medical claims; w...ial was available, only a minority of company data... the majority of original research cited in the ad... product,s manufacturer. , In one of the largest ...
...eam of Fox Chase Cancer Center scientists led by i...ed the genetic mutation that keeps a mouse strain ... called helper T cells. The report by Kappes and h...re. , Kappes, laboratory first discovered the mic...e,s laboratory animal facility in 1997. Known as "...
... the first time, researchers have,automatically gr...lution images of cells. This technical feat opens ...rgets by helping to show which,proteins cluster to...arnegie Mellon University, outperforms,existing vi...ys,Professor Robert F. Murphy, whose report, "Data...
Other Biology News:UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims 2UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims 3Fox Chase Cancer Center scientists identify immune-system mutation 2New, automated tool successfully classifies and relates proteins in unprecedented way 2
...yacrylamide gel electrophoresis (2D-PAGE) with bio...core technology platform for proteomic analysis. 2... complex samples limited only in the dynamic range...Quantitative image based analysis of separated pro...
LabWorks Analysis Software from UVP
...apor Trap Models RVT100, RVT400, RVT405DDA, RVT410... UVS400A and UVS800DDA., A non-corrosive, odorles...or use for temperatures ranging from -105 to +260 ...ability and does not evaporate. Far superior to dr...
... is a concentrated formulation of a rinsing buffer...n technology, as well as for manual immunostaining...gati M.D., Department of Pathology, University of ...ended for all the rinsing steps performed when doi...
Biology Products: